跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
CENVITE TABLET
Approved
THERAPEUTIC
CENVITE TABLET
SUNWARD PHARMACEUTICAL PRIVATE LIMITED (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
Jun 5, 1992
Approval ID
b578549324cf3b74
Company
SUNWARD PHARMACEUTICAL PRIVATE LIMITED (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
b578549324cf3b74
Drug Name
CENVITE TABLET
Product Name
CENVITE TABLET
Approval Number
SIN07046P
Approval Date
1992-06-05
Registrant
CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Licence Holder
CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
A02AD01
Atc Item Name
ordinary salt combinations
Pharma Manufacturer Name
CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Active Ingredients
SIMETHICONE
30 mg
ALUMINIUM HYDROXIDE (DRIED GEL)
250 mg
MAGNESIUM TRISILICATE
250 mg
ALUMINIUM HYDROXIDE (DRIED GEL)
250 MG
MAGNESIUM TRISILICATE
250 MG
SIMETHICONE
30 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 5, 1992
Approval ID
b578549324cf3b74
Type
Therapeutic
Back to HSA Approvals
CENVITE TABLET - HSA Drug Approval Details